Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effect of Baduanjin Exercise on Pain, Fatigue, and Quality of Recovery After Abdominal Surgery

3 de novembro de 2026 atualizado por: Niran Çoban, University of Yalova

The Effect of Baduanjin Exercise on Pain, Fatigue, and Quality of Recovery in Patients Undergoing Abdominal Surgery: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of Baduanjin exercise on pain, fatigue, fatigue severity, and quality of recovery in patients undergoing abdominal surgery.

A total of 60 participants will be randomly assigned to an intervention group or a control group. Before surgery, participants in the intervention group will receive instruction in Baduanjin exercises and perform the exercises once to learn the technique. After hospital discharge, they will continue the Baduanjin exercise program three days per week for six weeks. Participants in the control group will receive standard hospital care without Baduanjin exercise.

At the end of weeks 3 and 6, pain, fatigue, fatigue severity, and quality of recovery will be assessed using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively. Outcomes will be compared between the intervention and control groups.

Visão geral do estudo

Status

Ainda não está recrutando

Intervenção / Tratamento

Descrição detalhada

This study aims to evaluate the effects of Baduanjin exercise on pain, fatigue, fatigue severity, and quality of recovery in patients undergoing abdominal surgery. The study is planned as a randomized, controlled, pretest-posttest experimental study involving 60 patients undergoing abdominal surgery at Gümüşhane State Hospital, Türkiye. Participants will be randomly assigned to an intervention group (n=30) or a control group (n=30). Before surgery, participants in the intervention group will be taught how to perform Baduanjin exercises and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Participants in the control group will receive standard hospital care without Baduanjin exercise. At the end of weeks 3 and 6, outcomes will be assessed in both groups using the Visual Analog Scale (VAS) to measure pain intensity, the Fatigue Scale to assess fatigue, the Fatigue Severity Scale to assess fatigue severity, and the Quality of Recovery-40 (QoR-40) questionnaire to evaluate quality of recovery. The results will be compared between the intervention and control groups to determine the effects of the Baduanjin exercise program on pain, fatigue, fatigue severity, and quality of recovery following abdominal surgery.

Tipo de estudo

Intervencional

Inscrição (Estimado)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 70 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Patients aged 18 years and older and younger than 70 years.
  • Patients undergoing abdominal surgery.
  • Patients who voluntarily agree to participate in the study and provide informed consent.
  • Patients with a body mass index (BMI) below 40 kg/m².
  • Patients with a Standardized Mini-Mental State Examination score of 24 or higher.
  • Patients who are able to read and write.

Exclusion Criteria:

  • Patients with communication or comprehension difficulties.
  • Patients who receive sedation.
  • Patients who have difficulty understanding or speaking Turkish.
  • Patients with a psychiatric disorder who are receiving medication.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: Standart care

Participants in this group will receive standard hospital care without Baduanjin exercise. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively.

Experimental: Baduanjin Exercise Group

Participants in this group will receive instruction in Baduanjin exercises before surgery and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively.

Participants in the intervention group will be taught Baduanjin exercises before surgery and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
The Effect of Baduanjin on Pain
Prazo: At the end of weeks 3 and 6 after hospital discharge.

Visual Analog Scale (VAS): The Visual Analog Scale (VAS) is a commonly used tool for assessing pain. It consists of a 10-cm (100-mm) line ranging from 0 (no pain) to 10 (worst imaginable pain). In this study, the VAS will be used to assess pain in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on pain.

At the end of weeks 3 and 6 after hospital discharge.
The Effect of Baduanjin on Fatigue
Prazo: At the end of weeks 3 and 6 after hospital discharge.

Fatigue Scale (FS): The Fatigue Scale was developed by Beurskens et al. in 2000 to assess chronic fatigue. The scale consists of 20 items and evaluates fatigue over the previous two weeks across four dimensions: subjective fatigue perception, concentration, motivation, and physical activity. The Turkish version was validated by Ergin et al. in 2009. The total score ranges from 20 to 140, with higher scores indicating greater chronic fatigue. In this study, the Fatigue Scale will be used to assess fatigue in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on fatigue.

At the end of weeks 3 and 6 after hospital discharge.
The Effect of Baduanjin Exercise on Fatigue Severity
Prazo: At the end of weeks 3 and 6 after hospital discharge.

Fatigue Severity Scale (FSS): The Fatigue Severity Scale was developed by Krupp et al. in 1989 to assess fatigue severity, initially in patients with multiple sclerosis and systemic lupus erythematosus. It consists of nine items assessing the subjective severity of fatigue during the previous week. Each item is rated on a seven-point scale, and the total score is calculated as the arithmetic mean of the item scores. Higher scores indicate greater fatigue severity, and a score of approximately 4 or above generally suggests substantial fatigue. The Turkish validity and reliability study was conducted by Gencay Can et al. in 2012. In this study, the Fatigue Severity Scale will be used to assess fatigue severity in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on fatigue severity.

At the end of weeks 3 and 6 after hospital discharge.
The Effect of Baduanjin Exercise on Quality of Recovery
Prazo: At the end of weeks 3 and 6 after hospital discharge.

Quality of Recovery-40 (QoR-40): The Quality of Recovery-40 (QoR-40) was developed by Myles et al. in 2000 and its Turkish validity and reliability were evaluated by Karaman et al. in 2014. The questionnaire consists of 40 items across five dimensions: emotional state, physical comfort, patient support, physical independence, and pain. Each item is rated on a five-point Likert scale, and the total score ranges from 40 to 200. Higher scores indicate better postoperative physical and emotional well-being, whereas lower scores indicate poorer quality of recovery. In this study, the QoR-40 will be used to assess quality of recovery in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on postoperative recovery.

At the end of weeks 3 and 6 after hospital discharge.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Investigadores

  • Diretor de estudo: Nurşen Kulakaç, Assoc. Prof., Gümüşhane Universıty

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

30 de outubro de 2026

Conclusão Primária (Estimado)

20 de dezembro de 2026

Conclusão do estudo (Estimado)

20 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

24 de outubro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

24 de outubro de 2026

Primeira postagem (Real)

30 de outubro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

9 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

3 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • NCNK

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever